Cargando…

DNA-PK inhibition extends the therapeutic effects of Top2 poisoning to non-proliferating cells, increasing activity at a cost

Type II topoisomerase (Top2) poisoning therapy is used to treat a broad range of cancers via induction of double strand breaks (DSBs) in cells undergoing replication and transcription. Preventing the repair of DSBs via inhibition of DNA-PK, an inhibitor of non-homologous end-joining (NHEJ), increase...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Taixiang, Kyle, Alastair H., Baker, Jennifer H. E., Liu, Nannan A., Banáth, Judit P., Minchinton, Andrew I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394067/ https://www.ncbi.nlm.nih.gov/pubmed/37528151 http://dx.doi.org/10.1038/s41598-023-39649-7

Ejemplares similares

DNA-PK as an Emerging Therapeutic Target in Cancer
por: Mohiuddin, Ismail S., et al.
Publicado: (2019)

Inter-Metastatic Heterogeneity of Tumor Marker Expression and Microenvironment Architecture in a Preclinical Cancer Model
por: Kalra, Jessica, et al.
Publicado: (2021)

Immunoregulatory Cell Depletion Improves the Efficacy of Photodynamic Therapy-Generated Cancer Vaccines
por: Korbelik, Mladen, et al.
Publicado: (2015)

Concerns about pharmacokinetic (PK) and pharmacokinetic-pharmacodynamic (PK-PD) studies in the new therapeutic area of COVID-19 infection
por: Venisse, Nicolas, et al.
Publicado: (2020)

Characterization of prickle isoform-specific pk (pk1) and pk (sple1) mutations in Drosophila melanogaster
por: Lilienthal, Anthony J, et al.
Publicado: (2022)

Plasmodium knowlesi (Pk) Malaria: A Review & Proposal of Therapeutically Rational Exchange (T-REX) of Pk-Resistant Red Blood Cells
por: Jajosky, Ryan Philip, et al.
Publicado: (2023)

Targeting the Tumour Vasculature: Exploitation of Low Oxygenation and Sensitivity to NOS Inhibition by Treatment with a Hypoxic Cytotoxin
por: Baker, Jennifer H. E., et al.
Publicado: (2013)

Formic and acetic acid pK(a) values increase under nanoconfinement
por: Sit, Izaac, et al.
Publicado: (2023)

Dosimetry with a clinical linac adapted to FLASH electron beams
por: Szpala, Stanislaw, et al.
Publicado: (2021)

Effect of prolonging radiation delivery time on retention of gammaH2AX
por: Moiseenko, Vitali, et al.
Publicado: (2008)

Unraveling the Effect of Immunogenicity on the PK/PD, Efficacy, and Safety of Therapeutic Proteins
por: Smith, Alison, et al.
Publicado: (2016)

Increased Non-Homologous End Joining Makes DNA-PK a Promising Target for Therapeutic Intervention in Uveal Melanoma
por: Doherty, Rachel E., et al.
Publicado: (2019)

Calreticulin as Cancer Treatment Adjuvant: Combination with Photodynamic Therapy and Photodynamic Therapy-Generated Vaccines
por: Korbelik, Mladen, et al.
Publicado: (2015)

1321. Population Pharmacokinetic (PK) and Pharmacokinetic/Pharmacodynamic (PK/PD) Target Attainment Analyses for Dalbavancin in Pediatric Patients
por: Carrothers, Timothy J, et al.
Publicado: (2020)

Increasing interest in PK and PD studies has many advantages for anesthesiologists
por: Woo, Young-Cheol
Publicado: (2011)

Residual γH2AX foci as an indication of lethal DNA lesions
por: Banáth, Judit P, et al.
Publicado: (2010)

The differential effects of metronomic gemcitabine and antiangiogenic treatment in patient-derived xenografts of pancreatic cancer: treatment effects on metabolism, vascular function, cell proliferation, and tumor growth
por: Yapp, Donald T., et al.
Publicado: (2016)

A novel therapeutic anti-HBV antibody with increased binding to human FcRn improves in vivo PK in mice and monkeys
por: Kang, Ciming, et al.
Publicado: (2017)

Complete Genome Sequence of the Pokeweed Mosaic Virus (PkMV)-New Jersey Isolate and Its Comparison to PkMV-MD and PkMV-PA
por: Di, Rong
Publicado: (2016)

Ribosomal protein S11 influences glioma response to TOP2 poisons
por: Awah, Chidiebere U, et al.
Publicado: (2020)

Heterogeneous distribution of trastuzumab in HER2-positive xenografts and metastases: role of the tumor microenvironment
por: Baker, Jennifer Hazel Elizabeth, et al.
Publicado: (2018)

A potential cost of evolving epibatidine resistance in poison frogs
por: York, Julia M., et al.
Publicado: (2023)

PK-modifying anchors significantly alter clearance kinetics, tissue distribution, and efficacy of therapeutics siRNAs
por: Godinho, Bruno M.D.C., et al.
Publicado: (2022)

Molecular characterization of a porcine teschovirus HuN-1 isolate proliferating in PK-15 cell
por: Chen, Molin, et al.
Publicado: (2018)

Visualization of a DNA-PK/PARP1 complex
por: Spagnolo, Laura, et al.
Publicado: (2012)

Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): Extending the CONSORT Statement
por: MacPherson, Hugh, et al.
Publicado: (2010)

Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): extending the CONSORT statement
por: MacPherson, Hugh, et al.
Publicado: (2010)

A generic whole body physiologically based pharmacokinetic model for therapeutic proteins in PK-Sim
por: Niederalt, Christoph, et al.
Publicado: (2017)

Population PK/PD modelling of meropenem in preterm newborns based on therapeutic drug monitoring data
por: Zyryanov, Sergey, et al.
Publicado: (2023)

Benchmarking pK(a )prediction
por: Davies, Matthew N, et al.
Publicado: (2006)

In silico pK(a) prediction
por: Körner, Robert, et al.
Publicado: (2012)

Ceftobiprole: pharmacokinetics and PK/PD profile
por: Azanza Perea, José Ramón, et al.
Publicado: (2019)

III. TOLERANCE FOR MERCURY POISONING INCREASED BY FREQUENT HEMOGLOBIN INJECTIONS
por: Havill, William H., et al.
Publicado: (1932)

Cell killing and DNA damage by etoposide in Chinese hamster V79 monolayers and spheroids: influence of growth kinetics, growth environment and DNA packaging.
por: Olive, P. L., et al.
Publicado: (1993)

In vitro dynamic pharmacokinetic/pharmacodynamic(PK/PD) modeling and PK/PD cutoff of cefquinome against Haemophilus parasuis
por: Xiao, Xia, et al.
Publicado: (2015)

Joint analysis of PK and immunogenicity outcomes using factorization model − a powerful approach for PK similarity study
por: Haliduola, Halimu N., et al.
Publicado: (2022)

Population PK and Semimechanistic PK/PD Modeling and Simulation of Relugolix Effects on Testosterone Suppression in Men with Prostate Cancer
por: Lee, Tien‐Yi, et al.
Publicado: (2022)

Inhibition of Japanese encephalitis virus proliferation by long non-coding RNA SUSAJ1 in PK-15 cells
por: Zhou, Xiaolong, et al.
Publicado: (2021)

Rhabdomyolysis following Acute Extended-Release Quetiapine Poisoning: A Case Report
por: Liolios, Antonios, et al.
Publicado: (2012)

The impact of poisoning in British Columbia: a cost analysis
por: Rajabali, Fahra, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8hkbb0ar30u4blbobgv93t7vpn